Tweet from ScottGottliebMD at May 10, 2022 at 01:41PM
New analysis shows that the long term, neutralizing antibodies produced after recovery from a primary Omicron infection (in absence of vaccination) have a narrow specificity, suggesting they’re unlikely to provide robust protection against novel variants
https://t.co/ztndkmCvoP https://t.co/DODC6XvUol
— Scott Gottlieb, MD (@ScottGottliebMD)
May 10, 2022
from http://twitter.com/ScottGottliebMD